Clinical Trials Directory

Trials / Completed

CompletedNCT02660931

Pediatric Acute Kidney Injury (AKI) Retrospective, Real-Time and Repository Research

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
12,108 (actual)
Sponsor
Vanderbilt University Medical Center · Academic / Other
Sex
All
Age
28 Days – 21 Years
Healthy volunteers
Not accepted

Summary

This proposal will incorporate statistical models developed by the investigators to predict risk for acute kidney injury into our electronic medical record system, enabling an alert to notify providers of the risk status. Pediatric inpatients will be randomly assigned to be in the intervention group, for whom the notification will be implemented, or in the control group, who will receive usual care (no notification). The investigators believe the notification will increase appropriate screening for acute kidney injury and reduce the severity of acute kidney injury in the intervention group.

Detailed description

This proposal will incorporate a logistic regression models developed by the investigators to predict risk for acute kidney injury in pediatric intensive care unit and pediatric ward patients into the electronic medical record system, enabling personalized decision support. Real-time surveillance using the risk prediction models will identify pediatric inpatients at increased risk for acute kidney injury. When patients exceed the threshold risk for acute kidney injury, the electronic medical record system will notify providers. Patients will be randomly assigned to be in the intervention group, for whom the notification will be implemented, or in the control group, for whom the notification will not display. The risk notification will be assessed for its impact on outcomes including rates of screening for acute kidney injury and the severity of acute kidney injury.

Conditions

Interventions

TypeNameDescription
OTHERAKI Risk NotificationWhen a patient's calculated acute kidney injury risk exceeds the threshold value, the electronic medical record will notify the provider of the risk and that appropriate screening (BMP including serum creatinine) may be indicated.

Timeline

Start date
2016-11-01
Primary completion
2017-11-01
Completion
2018-11-01
First posted
2016-01-21
Last updated
2019-04-03

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02660931. Inclusion in this directory is not an endorsement.